Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 08-2011 | 12-2010 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 1,529 | 1,529 | N/A |
| Marketable Securities | N/A | 2,186 | 2,186 | N/A |
| Receivables | 85 | 567 | 567 | N/A |
| Other current assets | 10 | 0 | 2 | 0 |
| TOTAL | $95 | $4,284 | $4,284 | $N/A |
| Non-Current Assets | ||||
| PPE Net | N/A | 17 | 17 | N/A |
| Investments And Advances | 0 | 10 | 0 | 0 |
| Other Non-Current Assets | 0 | 14 | 0 | 0 |
| TOTAL | $N/A | $42 | $17 | $N/A |
| Total Assets | $95 | $4,326 | $4,326 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 441 | 0 | 0 |
| TOTAL | $N/A | $441 | $441 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 161 | 0 | 0 |
| TOTAL | $N/A | $161 | $N/A | $N/A |
| Total Liabilities | $N/A | $602 | $602 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | N/A | 70 | 0 | N/A |
| Retained earnings | N/A | -14,547 | -14,547 | N/A |
| Other shareholders' equity | -4 | 0 | 18,271 | 0 |
| TOTAL | $-4 | $3,724 | $3,724 | $N/A |
| Total Liabilities And Equity | $-4 | $4,326 | $4,326 | $0 |